Biotech giant Amgen (AMGN) has announced that it is buying Horizon Therapeutics (HZNP) for a whopping $26.4 billion, or $116.50 per share in cash. Click to get this free report Amgen Inc. (AMGN) : Free Stock Analysis Report Horizon Therapeutics Public Limited Company (HZNP) : Free Stock Analysis Report Coupa Software, Inc. (COUP) : Free Stock Analysis Report To read this article on Zacks.com click here. Elsewhere, we do see more economic activity throughout this week, not the least of which is the November print on the Consumer Price Index (CPI) — the same day the FOMC meeting commences.